Renaissance Technologies’s NLS Pharmaceutics NLSP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-544
| Closed | -$4.72K | – | 3770 |
|
|
2024
Q2 | $4.72K | Sell |
544
-3,945
| -88% | -$34.3K | ﹤0.01% | 3441 |
|
|
2024
Q1 | $32K | Buy |
4,489
+4,172
| +1,316% | +$29.7K | ﹤0.01% | 3545 |
|
|
2023
Q4 | $7K | Sell |
317
-211
| -40% | -$4.66K | ﹤0.01% | 3660 |
|
|
2023
Q3 | $15K | Sell |
528
-840
| -61% | -$23.9K | ﹤0.01% | 3555 |
|
|
2023
Q2 | $60K | Buy |
1,368
+565
| +70% | +$24.8K | ﹤0.01% | 3581 |
|
|
2023
Q1 | $49K | Buy |
803
+298
| +59% | +$18.2K | ﹤0.01% | 3671 |
|
|
2022
Q4 | $26K | Sell |
505
-140
| -22% | -$7.21K | ﹤0.01% | 3916 |
|
|
2022
Q3 | $16K | Buy |
645
+145
| +29% | +$3.6K | ﹤0.01% | 3921 |
|
|
2022
Q2 | $12K | Sell |
500
-43
| -8% | -$1.03K | ﹤0.01% | 4154 |
|
|
2022
Q1 | $31K | Buy |
543
+273
| +101% | +$15.6K | ﹤0.01% | 3966 |
|
|
2021
Q4 | $12K | Buy |
+270
| New | +$12K | ﹤0.01% | 3855 |
|
|
2021
Q3 | – | Sell |
-1,050
| Closed | -$132K | – | 3717 |
|
|
2021
Q2 | $132K | Buy |
+1,050
| New | +$132K | ﹤0.01% | 3326 |
|